References
Alevizaki M, Mantzou E, Cimponeriu AT, Alevizaki CC, Koutras DA (2005) TSH may not be a good marker for adequate thyroid hormone replacement therapy. Wien Klin Wochenschr 117: 636–640
Pugeat M, Crave JC, Tourniaire J, Forest MG (1996) Clinical utility of sex hormone-binding globuline measurement. Horm Res 45: 148–155
Brenta G, Schnitman M, Gurfinkiel M, Damilano S, Pierini A, Sinay I, Pisarev MA (1999) Variations of sex hormone-binding globulin in thyroid dysfunction. Thyroid 9: 273–277
Klein I, Ojamaa K (2001) Thyroid hormone and the cardiovascular system. N Engl J Med 344: 501–509
Bartalena L, Bogazzi F, Martino E (1996) Adverse effects of thyroid hormone preparations and antithyroid drugs. Drug Saf 15: 53–63
Rights and permissions
About this article
Cite this article
Staudenherz, A., Sinzinger, H. TSH may not be a good marker for adequate thyroid hormone replacement therapy. Wien Klin Wochenschr 118, 365–367 (2006). https://doi.org/10.1007/s00508-006-0619-9
Issue Date:
DOI: https://doi.org/10.1007/s00508-006-0619-9